CIK 0001477845
- Non-accelerated filer
- Smaller reporting company
Annovis Bio, Inc.
Sign in to watch- Ticker
- ANVS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262540421
- Phone
- +1 484-875-3192
- Business address
- 101 LINDENWOOD DRIVE, SUITE 225, MALVERN, PA, 19355
- Former names
- QR Pharma, Inc.
- 4 Derivatives Options or other derivatives
- 4 Gift President and CEO gave 30,000 shares (gift)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Grant or award Director acquired 1,990 shares (grant or award)
- 4/A Other acquisition Director acquired 0 shares (other)
- 4/A Grant or award Director acquired 163,880 shares (grant or award)
- 4/A Grant or award President and CEO acquired 40,970 shares (grant or award)
- 4/A Grant or award Chief Financial Officer acquired 820 shares (grant or award)
- 4/A Other acquisition Director acquired 0 shares (other)
- 4 Grant or award Director acquired 824 shares (grant or award)
- 4 Grant or award Director acquired 164,745 shares (grant or award)
- 4 Grant or award Director acquired 2,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 41,186 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 824 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Gift President and CEO gave 3,000 shares (gift)
- 4 Grant or award Director acquired 3,000 shares (grant or award)
- 4 Grant or award Director acquired 500 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 1,000 shares (grant or award)
Page 2 of 5 · 91 filings